Medians and correction factors for biochemical and ultrasound markers in Chinese women undergoing first-trimester screening for trisomy 21

Ultrasound in Obstetrics and Gynecology

Volumn 33, Issue 4, 2009, Pages 387-393

  Sahota, D S ^a   Leung, T Y ^a   Fung, T Y ^a   Chan, L W ^a   Law, L W ^a   Lau, T K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Chinese; Fetal nuchal translucency; Free hCG; PAPP A; Screening

Indexed keywords

BIOCHEMICAL MARKER; CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADOLESCENT; ADULT; ANEUPLOIDY; ARTICLE; BLOOD ANALYSIS; CHINESE; CHROMOSOME ANALYSIS; CONCEPTION; CONTROLLED STUDY; CROWN RUMP LENGTH; DOWN SYNDROME; ETHNICITY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MATERNAL SERUM; MATERNAL SMOKING; NUCHAL TRANSLUCENCY MEASUREMENT; PARITY; PREGNANCY OUTCOME; PRENATAL SCREENING; PRIORITY JOURNAL; TRISOMY 21; TWIN PREGNANCY; ULTRASOUND;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CROWN-RUMP LENGTH; DOWN SYNDROME; EPIDEMIOLOGIC METHODS; FEMALE; FETAL DISEASES; GESTATIONAL AGE; HONG KONG; HUMANS; MALE; MATERNAL AGE; MIDDLE AGED; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; REFERENCE VALUES; YOUNG ADULT;

EID: 63449131569     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.6340     Document Type: Article

References (31)

1. Nicolaides KH. First-trimester screening for chromosomal abnormalities. Semin Perinatol 2005; 29: 190-194.
2. Neveux LM, Palomaki GE, Larrivee DA, Knight GJ, Haddow JE. Refinements in managing maternal weight adjustment for interpreting prenatal screening results. Prenat Diagn 1996; 16: 1115-1119.
3. Spencer K, Bindra R, Nicolaides KH. Maternal weight correction of maternal serum PAPP-A and free beta-hCG MoM when screening for trisomy 21 in the first trimester of pregnancy. Prenat Diagn 2003; 23: 851-855.
4. Spencer K, Heath V, El-Sheikhah A, Ong CY, Nicolaides KH. Ethnicity and the need for correction of biochemical and ultrasound markers of chromosomal anomalies in the first trimester: a study of Oriental, Asian and Afro-Caribbean populations. Prenat Diagn 2005; 25: 365-369.
5. Leung TY, Spencer K, Leung TN, Fung TY, Lau TK. Higher median levels of free beta-hCG and PAPP-A in the first trimester of pregnancy in a Chinese ethnic group. Implication for first trimester combined screening for Down's syndrome in the Chinese population. Fetal Diagn Ther 2006; 21: 140-143.
6. Ardawi MS, Nasrat HA, Rouzi AA, Qari MH, Al-Qahtani MH, Abuzenadah AM. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women. Prenat Diagn 2007; 27: 303-311.
7. Spencer K, Bindra R, Cacho AM, Nicolaides KH. The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy. Prenat Diagn 2004; 24: 169-173.
8. Niemimaa M, Heinonen S, Seppälä M, Ryynänen M. The influence of smoking on the pregnancy-associated plasma protein A, free beta human chorionic gonadotrophin and nuchal translucency. BJOG 2003; 110: 664-667.
9. Kagan KO, Frisova V, Nicolaides KH, Spencer K. Dose dependency between cigarette consumption and reduced maternal serum PAPP-A levels at 11-13 + 6 weeks of gestation. Prenat Diagn 2007; 27: 849-853.
10. Ardawi MS, Nasrat HA, Rouzi AA, Qari MH, Al-Qahtani MH, Abuzenadah AM. The effect of cigarette or sheesha smoking on first-trimester markers of Down syndrome. BJOG 2007; 114: 1397-1401.
11. Spencer K, Nicolaides KH. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience. BJOG 2003; 110: 276-280.
12. Niemimaa M, Suonpää M, Heinonen S, Seppälä M, Bloigu R, Ryynänen M. Maternal serum human chorionic gonadotrophin and pregnancy-associated plasma protein A in twin pregnancies in the first trimester. Prenat Diagn 2002; 22: 183-185.
13. Spencer K, Kagan KO, Nicolaides KH. Screening for trisomy 21 in twin pregnancies in the first trimester: an update of the impact of chorionicity on maternal serum markers. Prenat Diagn 2008; 28: 49-52.
14. Liao AW, Heath V, Kametas N, Spencer K, Nicolaides KH. First-trimester screening for trisomy 21 in singleton pregnancies achieved by assisted reproduction. Hum Reprod 2001; 16: 1501-1504.
15. Niemimaa M, Heinonen S, Seppälä M, Hippeläinen M, Martikainen H, Ryynänen M. First-trimester screening for Down's syndrome in in-vitro fertilization pregnancies. Fertil Steril 2001; 76: 1282-1283.
16. nd edn). Cambridge University Press: Cambridge, 2006.
17. rd edn). Harcourt Brace College Publishers: Fort Worth, TX, 1997.
18. Thilaganathan B, Khare M, Williams B, Wathen NC. Influence of ethnic origin on nuchal translucency screening for Down's syndrome. Ultrasound Obstet Gynecol 1998; 12: 112-114.
19. Chen M, Lam YH, Tang MH, Lee CP, Sin SY, Tang R, Wong HS, Wong SF. The effect of ethnic origin on nuchal translucency at 10-14 weeks of gestation. Prenat Diagn 2002; 22: 576-578.
20. Jou HJ, Wu SC, Li TC, Hsu HC, Tzeng CY, Hsieh FJ. Relationship between fetal nuchal translucency and crown-rump length in an Asian population. Ultrasound Obstet Gynecol 2001; 17: 111-114.
21. Logghe H, Cuckle H, Sehmi I. Centre-specific ultrasound nuchal translucency medians needed for Down syndrome screening. Prenat Diagn 2003; 23: 389-392.
22. Tsukerman GL, Gusina NB, Cuckle HS. Maternal serum screening for Down syndrome in the first trimester: experience from Belarus. Prenat Diagn 1999; 19: 499-504.
23. de Graaf IM, Cuckle HS, Pajkrt E, Leschot NJ, Bleker OP, van Lith JM. Co-variables in first trimester maternal serum screening. Prenat Diagn 2000; 20: 186-189.
24. Krantz DA, Hallahan TW, Macri VJ, Macri JN. Maternal weight and ethnic adjustment within a first-trimester Down syndrome and trisomy 18 screening program. Prenat Diagn 2005; 25: 635-640.
25. Liao AW, Heath V, Kametas N, Spencer K, Nicolaides KH. First-trimester screening for trisomy 21 in singleton pregnancies achieved by assisted reproduction. Hum Reprod 2001; 16: 1501-1504.
26. Yigiter AB, Kavak ZN, Bakirci N, Gokaslan H. Effect of smoking on pregnancy-associated plasma protein A, free beta-human chorionic gonadotropin, and nuchal translucency in the first trimester of pregnancy. Adv Ther 2006; 23: 131-138.
27. Spencer K. Screening for trisomy 21 in twin pregnancies in the first trimester: does chorionicity impact on maternal serum free β-hCG or PAPP-A levels? Prenat Diagn 2001; 20: 715-717.
28. Goncé A, Borrell A, Fortuny A, Casals E, Martínez MA, Mercadé I, Cararach V, Vanrell JA. First-trimester screening for trisomy 21 in twin pregnancy: does the addition of biochemistry make an improvement? Prenat Diagn 2005; 25: 1156-1161.
29. Wøjdemann KR, Larsen SO, Shalmi AC, Sundberg K, Tabor A, Christiansen M. Nuchal translucency measurements are highly correlated in both mono- and dichorionic twin pairs. Prenat Diagn 2006; 26: 218-220.
30. Mashiach R, Orr-Urtreger A, Yaron Y. A comparison between maternal serum free beta-human chorionic gonadotrophin and pregnancy-associated plasma protein A levels in first-trimester twin and singleton pregnancies. Fetal Diagn Ther 2004; 19: 174-177.
31. Lau EMC, Lee P, Lynn H, Sham A, Woo J. The epidemiology of cigarette smoking in Hong Kong Chinese women. Prev Med 2003; 37: 383-388.